Arrowhead Pharma Cash Flow - Annual (NASDAQ:ARWR)

Add to My Stocks
$18.88 $0.3 (1.61%) ARWR stock closing price Sep 20, 2018 (Closing)

The Arrowhead Pharma cash flow statement is one of the three reports that the company generates every quarter. While its important to look at the Arrowhead Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Arrowhead Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Arrowhead Pharma saw a cash impact of $12.69M from the issuance of ARWR shares. The cash flow statement helps in the Arrowhead Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. ARWR decrease in investments stood at a value of $-48.64M for the latest year 2017.

View details of Arrowhead Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Oct - Sep2017201620152014201320122011201020092008
Net Income Cash Flow
-34.38M-81.72M-91.94M-58.63M-31.14M-21.12M-3.12M-5.77M-19.3M-27.08M
Depreciation Depletion Amortization Cash-Flow4.64M3.49M3.44M2.13M1.87M1.75M---1.13M
Net Increase (Decrease) in Assets Liabilities-1.2M5.71M3.4M5M----0.99M-0.82M-0.23M
Cash From (used in) Discontinued Operations-------5.29M-0.42M--
Other Adjustments Net7M8.08M19.37M16.06M10.09M3.81M--1.15M3.86M-1.39M
Net Cash from (used by) Operating Activities
-23.93M-64.42M-65.7M-35.41M-19.03M-15.34M-7.65M-7.69M-15.27M-27.58M
Increase (Decrease) in Prop Plant And Equipment-7.91M-3.86M-1.97M-1.7M-0.2M-0.18M-0.01M---0.68M
Acquisition Disposition of Subsidiaires---10M-------0.25M
Increase (Decrease) in Investments-40.72M17.3M26.09M-34.77M-9.31M-1.53M---1.64M
Other Cash Inflow (Outflow) from Investment Activities-------1.7M---
Net Cash from (used by) Investment Activities
-48.64M13.44M14.12M-36.48M-9.52M--0.17M---2.57M
Issuance (Purchase) of Equity Shares12.69M55.98M-185.51M44.5M10.96M4.5M12.16M2.75M7.25M
Issuance (Repayment) of Debt Securities--0.21M-0.21M-0.22M-0.21M-0.19M1.71M-0.12M3.7M8.87M
Increase (Decrease) in Bank & Other Borrowings-0.19M---------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.43M-0.63M--------
Net Cash from (used by) Financing Activities
12.05M55.13M-185.29M44.29M10.76M6.22M12.03M6.46M16.13M
Effect of Exchange Rate Changes on Cash------2.26M---
Net Change in Cash & Cash Equivalents
-60.52M4.15M-51.29M113.39M15.73M-4.13M-4.82M-8.07M-14.02M
Cash & Equivalents at Beginning of Year85.36M81.21M132.51M19.11M3.37M7.5M6.84M2.02M10.09M24.12M
Cash & Equivalents at Year End24.83M85.36M81.21M132.51M19.11M3.37M7.5M6.84M2.02M10.09M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Arrowhead Pharma stock price history and Arrowhead Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Arrowhead Pharma has cash of $24.83M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Arrowhead Pharma stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-23.93M for ARWR.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-48.64M for ARWR in last 2017 report.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Arrowhead Pharma earned $12.05M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Arrowhead Pharma Cash Flow